Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000597865 | SCV000707510 | uncertain significance | not provided | 2017-04-17 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001174894 | SCV001338317 | uncertain significance | not specified | 2020-02-19 | criteria provided, single submitter | clinical testing | Variant summary: COL9A3 c.1538C>T (p.Pro513Leu) results in a non-conservative amino acid change located in the Collagen triple helix repeat (IPR008160) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 6e-05 in 249484 control chromosomes (gnomAD). To our knowledge, no occurrence of c.1538C>T in individuals affected with Multiple epiphyseal dysplasia 3 and no experimental evidence demonstrating its impact on protein function have been reported. One ClinVar submitter (evaluation after 2014) cites the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. |
Athena Diagnostics Inc | RCV000597865 | SCV001475624 | uncertain significance | not provided | 2020-03-31 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000597865 | SCV001701809 | likely benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing |